Last updated on June 2019

Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients


Brief description of study

The objective of this post-marketing surveillance study is to observe the safety profile of Fycompa film-coated tablets 2/4/6/8/10/12 milligrams (mg) in a normal clinical practice setting.

Clinical Study Identifier: NCT02722590

Find a site near you

Start Over

Youngji Pyo

Busan, Korea, Republic of
  Connect »

Youngji Pyo

Chungju, Korea, Republic of
  Connect »

Youngji Pyo

Wonju, Korea, Republic of
  Connect »

Youngji Pyo

Seongnam, Korea, Republic of
  Connect »

Youngji Pyo

Jinju, Korea, Republic of
  Connect »

Youngji Pyo

Gwangju, Korea, Republic of
  Connect »

Youngji Pyo

Daegu, Korea, Republic of
  Connect »

Youngji Pyo

Daejeon, Korea, Republic of
  Connect »

Youngji Pyo

Seoul, Korea, Republic of
  Connect »